Format
Sort by
Items per page

Send to

Choose Destination

Best matches for guideline; hypertension; treatment:

Treatment of hypertension: The ESH/ESC guidelines recommendations. Cuspidi C et al. Pharmacol Res. (2018)

Initial Treatment of Hypertension. Taler SJ et al. N Engl J Med. (2018)

Hypertension. Poulter NR et al. Lancet. (2015)

Search results

Items: 1 to 20 of 7090

1.

Renal revascularization in resistant hypertension.

Prince M, Gupta A, Bob-Manuel T, Tafur J.

Prog Cardiovasc Dis. 2019 Dec 7. pii: S0033-0620(19)30161-6. doi: 10.1016/j.pcad.2019.12.001. [Epub ahead of print] Review.

PMID:
31821813
2.

Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresis.

Klingel R, Heigl F, Schettler V, Roeseler E, Gr├╝tzmacher P, Hohenstein B, Vogt A, Fassbender C, Heibges A, Julius U.

Atheroscler Suppl. 2019 Dec;40:17-22. doi: 10.1016/j.atherosclerosissup.2019.08.037.

PMID:
31818445
3.

PREMISE: Posterior Circulation Results Comparing Embolectomy to Medical Intervention in Stroke Emergencies.

Chen PM, Pirastehfar M, Hailey L, Morton M, Rapp KS, Agrawal K, Modir R, Meyer D, Meyer BC.

Cureus. 2019 Oct 25;11(10):e6000. doi: 10.7759/cureus.6000.

4.

The chaos of hypertension guidelines for chronic kidney disease patients.

Castillo-Rodriguez E, Fernandez-Fernandez B, Alegre-Bellassai R, Kanbay M, Ortiz A.

Clin Kidney J. 2019 Sep 28;12(6):771-777. doi: 10.1093/ckj/sfz126. eCollection 2019 Dec.

5.

Improving the use of intravenous antihypertensive medications in the hospital setting: a quality improvement initiative for patient safety.

Salman J, Salman A, Kumar S, Gjeka R, Tegeltija V, Peterson D, Chams N, Ross I.

BMJ Open Qual. 2019 Nov 27;8(4):e000626. doi: 10.1136/bmjoq-2019-000626. eCollection 2019.

6.

Medical Therapies for Heart Failure With Preserved Ejection Fraction.

Kjeldsen SE, von Lueder TG, Smiseth OA, Wachtell K, Mistry N, Westheim AS, Hopper I, Julius S, Pitt B, Reid CM, Devereux RB, Zannad F.

Hypertension. 2020 Jan;75(1):23-32. doi: 10.1161/HYPERTENSIONAHA.119.14057. Epub 2019 Dec 2.

PMID:
31786973
7.

Preliminary results of the acute Heart Failure registry in the DELTA region of Egypt (DELTA-HF): a database and a quality initiative project.

Elasfar A, Shaheen S, El-Sherbeny W, Elsokkary H, Elhefnawy S, Al-Setiha M.

Egypt Heart J. 2019 Nov 26;71(1):27. doi: 10.1186/s43044-019-0024-0.

8.

An international survey to inform priorities for new guidelines on von Willebrand disease.

Kalot MA, Al-Khatib M, Connell NT, Flood V, Brignardello-Petersen R, James P, Mustafa RA; VWD working group.

Haemophilia. 2019 Nov 26. doi: 10.1111/hae.13881. [Epub ahead of print]

PMID:
31769905
9.

Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.

Kittiskulnam P, Srijaruneruang S, Chulakadabba A, Thokanit NS, Praditpornsilpa K, Tungsanga K, Eiam-Ong S.

Am J Nephrol. 2019 Nov 21:1-11. doi: 10.1159/000504557. [Epub ahead of print]

PMID:
31752000
10.
11.

[Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].

Wang H, Li YY, Chai K, Zhang W, Li XL, Dong YG, Zhou JM, Huo Y, Yang JF.

Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Nov 24;47(11):865-874. doi: 10.3760/cma.j.issn.0253-3758.2019.11.004. Chinese.

PMID:
31744275
12.

A Bayesian Network Meta-analysis of Add-on Drug Therapies Specific for Pulmonary Arterial Hypertension.

Petrovi─Ź M, Locatelli I.

Ann Pharmacother. 2019 Nov 18:1060028019888760. doi: 10.1177/1060028019888760. [Epub ahead of print]

PMID:
31735058
13.

[Expert recommendations on standardized diagnosis and treatment for fatty liver disease in China (2019 revised edition)].

Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association; National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver and Metabolism, Chinese Society of Endocrinology, Chinese Medical Association.

Zhonghua Gan Zang Bing Za Zhi. 2019 Oct 20;27(10):748-753. doi: 10.3760/cma.j.issn.1007-3418.2019.10.003. Chinese.

PMID:
31734987
14.

Implications of Guideline Updates for the Management of Apparent Treatment Resistant Hypertension in the United States (A NCDR Research to Practice [R2P] Project).

Maw AM, Thompson LE, Ho PM, Kennedy KF, Maddox TM, Valle JA, Sandhu A, Masoudi FA, Messerli FH, Daugherty SL.

Am J Cardiol. 2019 Oct 11. pii: S0002-9149(19)31102-6. doi: 10.1016/j.amjcard.2019.09.033. [Epub ahead of print]

PMID:
31727262
15.

Prevalence and Determinants of hypertension in India based on the 2017 ACC/AHA Guideline: Evidence from the India National Family Health Survey.

Abariga SA, Khachan H, Kibria GMA.

Am J Hypertens. 2019 Nov 10. pii: hpz181. doi: 10.1093/ajh/hpz181. [Epub ahead of print]

PMID:
31711220
16.

Major adverse renal events (MARE): A proposal to unifying renal endpoints.

Prischl FC, Rossing P, Bakris G, Mayer G, Wanner C.

Nephrol Dial Transplant. 2019 Nov 11. pii: gfz212. doi: 10.1093/ndt/gfz212. [Epub ahead of print]

PMID:
31711188
17.

High prevalence of systemic hypertension in pediatric patients with moyamoya disease years after surgical treatment.

Lee J, Kim SK, Kang HG, Ha IS, Wang KC, Lee JY, Phi JH.

J Neurosurg Pediatr. 2019 Nov 8:1-7. doi: 10.3171/2019.9.PEDS1986. [Epub ahead of print]

PMID:
31703203
18.

Acute Severe Hypertension.

Peixoto AJ.

N Engl J Med. 2019 Nov 7;381(19):1843-1852. doi: 10.1056/NEJMcp1901117. Review. No abstract available.

PMID:
31693807
19.

Projection of new thresholds for hypertension to outpatient clinic patients and impact of risk factors: a cross-sectional study.

Aydogan U, Doganer YC, Ebiloglu A, Gok DE, Cirpan E, Saglam K.

Sao Paulo Med J. 2019 Oct 31;137(4):356-362. doi: 10.1590/1516-3180.2019.0111220719. eCollection 2019.

20.

Hyperbaric treatment of air or gas embolism: current recommendations.

Moon RE.

Undersea Hyperb Med. 2019 Sep - Dec - Fourth Quarter;46(5):673-683.

PMID:
31683367

Supplemental Content

Loading ...
Support Center